The sessions focused on emerging treatment approaches for neurological movement disorders, with particular emphasis on MR guided Focused Ultrasound (MRgFUS). Discussions addressed common patient perceptions, including the understanding of MRgFUS as a treatment limited to tremor control. Experts highlighted its broader clinical applications in select cases, including symptoms such as stiffness, slowness, walking difficulty, dyskinesia, and dystonia.

The forum included interactive patient engagement sessions, where attendees had the opportunity to directly consult with specialists. Key topics included treatment outcomes, suitability, and long-term considerations. Discussions also addressed concerns related to cost and recurrence, reinforcing the importance of transparent, evidence-based dialogue between patients and clinicians.

The Mumbai roadshow highlighted the need for continued collaboration across the healthcare ecosystem, including clinicians, institutions, industry stakeholders, and policymakers, to improve accessibility to advanced treatment technologies.

As part of the NeuroNext initiative conducted from March 13–15, 2026, the Mumbai forum contributed to the Foundation’s efforts to bridge the gap between medical innovation and patient awareness, enabling more informed healthcare decisions.